Zobrazeno 1 - 10
of 153
pro vyhledávání: '"F, Belpaire"'
Publikováno v:
Bulletin des Sociétés Chimiques Belges. 95:323-329
Pathways were investigated for the Cr transfer from the dialysate into the bloodstream as observed during continuous ambulatory peritoneal dialysis (CAPD). As the presence of Cr(VI) in the dialysate can be ruled out, due to reduction by lactate, a co
Autor:
N, Lameire, F, Belpaire
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 13
Autor:
F. Belpaire, F. H. M. Derkx, S. M. Bryson, A. W. Kelman, B. Whiting, E. S. M. Modderman, F. W. H. M. Merkus, H. W. Hilbers, J. Zuidema, J. A. M. Raai jmakers, G. K. Terpstra, G. A. Wassink, J. Kreukniet, T. B. Tjandramaga, R. Verbesselt, A. van Hecken, A. Mullie, P. J. de Schepper, M. E. J. van Hooff, M. A. van Baak, K. H. Rahn, F. Colardyn, D. Clement, P. L. C. M. van Riel, L. B. A. van de Putte, F. W. J. Gribnau, K. P. HacRae, T. B. Vree, C. A. Hekster, G. A. Verpooten, A. P. Buntinckx, L. Verbist, M. E. de Broe, H. H. Vincent, F. Boomsma, M. A. D. H. Schalekamp, H. J. M. van de Donk, G. S. M. J. E. Duchateau, G. J. Paulus, F. Roels, P. Tulkens, B. Winograd, M. J. M. Oosterbaan, H. Boerema, E. van der Kleijn, J. Monbaliu, J. J. Tukker, C. J. de Blaey, A. van Peer, R. Woestenborghs, J. Heykants, M. Verlinden, A. Reyntjens, R. J. M. Dirks, Th. Hallynck, J. Pijck, H. Soep, M. Lagas, J. H. G. Jonkman
Publikováno v:
Pharmaceutisch Weekblad. 5:35-40
Publikováno v:
Clinical and Experimental Dialysis and Apheresis. 6:65-73
The peritoneal elimination of digoxin during C.A.P.D. was studied in five patients. The plasma half life of digoxin varied from 54 hours to 141 hours. Only 7 to 24 micrograms was eliminated via the peritoneal route during 3 to 4 days C.A.P.D. treatme
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 3:29-33
Phenylbutazone was administered orally and intravenously at a dose of 5 mg/kg to healthy cows and to cows positive for bovine leukaemia virus (BLV). Pharmacokinetic parameters and bioavailability were investigated. No differences were seen in the par
Publikováno v:
Clinical Chemistry. 30:234-237
A quantitative assay based on endpoint immunonephelometry was developed for human apolipoprotein A-II (apoA-II) in plasma or serum. Dilution of plasma samples with a 0.1 mol/L solution of sodium cholate enhanced the quantification. We used either pur
Publikováno v:
Analytical Biochemistry. 116:204-210
The apo B quantitation by electroimmunoassay and immunonephelometry are compared for normal and pathological sera. The parameters affecting the accuracy and sensitivity of the assays, such as the selection of a suitable standard and the addition of a
Publikováno v:
Clinical Chemistry. 32:265-270
We developed a sensitive, specific "sandwich"-type enzyme-linked immunosorbent assay in which affinity-purified antibodies are used for coating and also for preparing an antibody-peroxidase conjugate to quantify apolipoprotein E in serum and in its l
Autor:
F. W. H. M. Merkus, F. W. J. Gribnau, Th. Thien, Hans W. Louwerenburg, J. Herre Kingma, Wiek H. van Gilst, A. Jacob Six, Pieter de Graeff, Harry Wesseling, J. R. BoeLaert, M. L. Schurgers, E. G. Matthys, F. Belpaire, R. F. Daneels, M. J. de Cre, M. G. Boqaert, P. C. D'Haese, G. A. Verpooten, L. V. Lamberts, L. Liang, M. E. de Broe, P. H. E. M. de Meijer, F. G. M. Russel, A. J. M. Russel, C. A. M. van Ginneken, B. M. van Liedekerke, W. E. Lambert, M. A. Yousouf, J. E. de Roose, A. P. de Leenheer, W. Lambert, J. de Bersaques, L. Vanneste, A. de Leenheer, S. de Marie, G. Slaghuis, P. M. Rozing, H. Mattie, F. G. J. Poelma, H. W. Hilbers, A. C. A. Jansen, J. J. Tukker, P. Augusti, N. Verbeke, A. van Peer, E. Snoeck, J. Heykants, J. Bruynseels, J. Peeters, W. Amery, V. Rogiers, Y. Vandenberghe, M. Comet, A. Callaerts, W. Sonck, A. Guillouzo, A. Vercruysse, P. van Rooy, N. Rombaut, G. vanden Bussche, A. C. I. T. L. Tan, T. L. Th. A. Jansen, E. F. S. Termond, P. W. C. Kloppenborg, Th. J. Benraad, V. van de Velde, R. Woestenbprghs, W. A. J. J. Hermens, S. G. Romeijn, M. J. M. Deurloo, G. Musch, D. L. Massart, M. van Hengstum, J. Festen, W. van den Broek, F. Corstens, C. Beurskens, M. Hankel, M. de Smet, S. J. P. van Belle, J. de May, G. A. Storme, P. J. K. Kuppen, H. Schuitemaker, L. J. van't Veer, A. T. van Oosterom, P. I. Schrier, E. A. de Bruijn, C. H. de Pooter, U. R. Tjaden, H. van Slooten, H. P. Roelevink, E. Smit, E. G. E. de Vries, J. Ijmker, D. R. A. Uges, M. Moors, K. Mertens, A. van Hecken, I. de Lepeleire, R. Verbesselt, T. B. Tjandra-Maga, P. J. de Schepper, P. J. M. Guelen, T. J. Jansen, W. P. Vrijhof, D. de Vos, S. Scharpé, R. Verkerk, N. Lsmeire, I. F. Zijlstra, F. M. Haaijer-Ruskamp, D. Post, P. F. Reddingius, H. Wesseling, H. C. H. Wollersheim, A. H. van den Meiracker, A. J. Man in 't Veld, P. Admiraal, F. Boomsma, F. Derkx, M. A. D. H. Schalekamp, D. F. Schoors, A. G. Dupont, F. Claessen, J. Reljenga, J. W. M. Lenders, Th. Thlen, G. Laekeman, L. Muylle, A. van Hoydonck, A. G. Herman, M. E. Peetermans
Publikováno v:
Pharmaceutisch Weekblad. 10:291-299
Publikováno v:
Life Sciences. 5:2085-2094